Clinical Trial Update: A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating photobiomodulation therapy for oral graft-versus-host disease in patients after stem cell transplantation; recruitment is ongo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Oral Graft-versus-host Disease

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Graft-Versus-Host Disease, GVHD | Phase 2 | Status: RECRUITING